Abstract
Mild Cognitive Impairment (MCI) is considered a transitional stage in the pathogenesis of Alzheimer’s disease; however, not all MCI patients progress to clinically defined AD or decline at identical rates. Hippocampal atrophy, as measured by Magnetic Resonance Imaging (MRI), may be a marker for hippocampal pathology in patients with MCI and predict a more rapid deterioration to clinical AD. In this study, we used MRI data from an ongoing MCI clinical trial to determine whether MRI hippocampal volume at baseline was associated with cognitive and functional performance in MCI subjects and whether it predicted those individuals who were more likely to develop AD. We performed correlational analyses between the MRI hippocampal volumes at study entry and the subjects’ concurrent performance on neuropsychological measures and clinical ratings. Larger hippocampal volume was associated with better performance on tests of memory, general cognition, and overall clinical ratings. Further analyses suggested that a smaller baseline hippocampal volume may be associated with a higher risk of developing clinical AD. As the trial is still ongoing, these results require confirmation once the trial is completed. In summary, these data suggest that MRI hippocampal volume may be a useful correlate of disease severity in MCI subjects and a prognostic indicator of subsequent AD.
Similar content being viewed by others
References
Folstein M. F., Folstein S. E., McHugh P. R. (1975) “Minimental state.” A practical method for grading the cognitive state of patients for the clinician. J. Psychiatric Res. 12, 189–198.
Grundman M., Petersen R. C., Morris J. C., et al. (1996) Rate of dementia of Alzheimer type (DAT) in subjects with mild cognitive impairment. The ADCS Cooperative Study. Neurology 46, A403.
Jack C. R., Jr., Bentley M., Twomey C. K., and Zinsmeister A. R. (1990) MR-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology 176, 205–209.
Jack C. R., Petersen R. C., Xu Y., et al. (2000) Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55, 484–489.
Jack C. R., Jr., Petersen R. C., Xu Y. C., et al. (1999) Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 52, 1397–1403.
Jack C. R., Jr., Petersen R. C., Xu Y. C., et al. (1997) Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 49, 786–794.
Morris J. C. (1997) Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int. Psychogeriatr. 9, 173–176; discussion 177–178.
Petersen R. C., Smith G. E., Ivnik R. J., et al. (1995) Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA 273, 1274–1278.
Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G., and Kokmen E. (1999) Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303–308.
Rosen W. G., Mohs R. C., and Davis K. L. (1984) A new rating scale for Alzheimer’s disease. Am. J. Psychiatry 141, 1356–1364.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Grundman, M., Sencakova, D., Jack, C.R. et al. Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci 19, 23–27 (2002). https://doi.org/10.1007/s12031-002-0006-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12031-002-0006-6